Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
63
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Suppressed Expression of CXCL14 in Hepatocellular Carcinoma Tissues and Its Reduction in the Advanced Stage of Chronic HBV Infection

Yong Lin1 Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China;2 Institution of Infectious Diseases, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China
,
Bo-Mei Chen3 Department of Human Resources, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China
,
Xiao-Lu Yu1 Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China
,
Huo-Chun Yi1 Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China
,
Jian-Jun Niu1 Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of China;2 Institution of Infectious Diseases, School of Medicine, Xiamen University, Xiamen361004, People’s Republic of ChinaCorrespondence[email protected]
&
Shu-Lian Li4 Department of Gynecology, Xiamen Huli District Maternity and Child Care Hospital, Xiamen361009, People’s Republic of ChinaCorrespondence[email protected]
Pages 10435-10443 | Published online: 12 Dec 2019

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
  • Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245. doi:10.1177/107327481772924528975830
  • de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62(4):1190–1200. doi:10.1002/hep.2796926146815
  • Cui F, Shen L, Li L, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi:10.3201/eid2305.16147728418296
  • Zheng R, Qu C, Zhang S, et al. Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chin J Cancer Res. 2018;30(6):571–579. doi:10.21147/j.issn.1000-9604.2018.06.0130700925
  • Niu J, Lin Y, Liu P, Yu Y, Su C, Wang X. Microarray analysis on the lncRNA expression profile in male hepatocellular carcinoma patients with chronic hepatitis B virus infection. Oncotarget. 2016;7(46):76169–76180.27769059
  • Wang W, Huang P, Zhang L, et al. Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Sci. 2013;104(11):1523–1531. doi:10.1111/cas.1227924033560
  • Hromas R, Broxmeyer HE, Kim C, et al. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun. 1999;255(3):703–706. doi:10.1006/bbrc.1999.025710049774
  • Frederick MJ, Henderson Y, Xu X, et al. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol. 2000;156(6):1937–1950. doi:10.1016/S0002-9440(10)65067-510854217
  • Sjöberg E, Augsten M, Bergh J, Jirström K, Östman A. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer. Br J Cancer. 2016;114(10):1117–1124. doi:10.1038/bjc.2016.10427115465
  • Kato N, Ji G, Wang Y, et al. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology. 2005;42(4):846–853. doi:10.1002/hep.v42:416175604
  • Ito S, Ozawa S, Ikoma T, Yajima N, Kiyono T, Hata R. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo. Biomed Res. 2010;31(3):199–206. doi:10.2220/biomedres.31.19920622470
  • Starnes T, Rasila KK, Robertson MJ, et al. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp Hematol. 2006;34(8):1101–1105. doi:10.1016/j.exphem.2006.05.01516863917
  • Gu X, Wang H, Wang A, et al. An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population. Mol Biol Rep. 2012;39(2):797–803. doi:10.1007/s11033-011-0801-721556757
  • Tangkijvanich P, Kongtawelert P, Pothacharoen P, Mahachai V, Suwangool P, Poovorawan Y. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Asian Pac J Allergy Immunol. 2003;21(2):115–120.14629129
  • Williams KA, Lee M, Hu Y, et al. A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes. PLoS Genet. 2014;10(11):e1004809. doi:10.1371/journal.pgen.100480925411967

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.